Treatment response and short-term outcomes in children admitted as multisystem inflammatory syndrome in children
Background: Multisystem inflammatory syndrome in children (MIS-C) is a postviral complication that has been described among children after 2–6 weeks of exposure to the COVID-19 virus from various parts of the world. Published literature regarding MIS-C in children is limited. The aim of this study w...
Main Authors: | Mousin Mustafa Batt, Ghanshyam S Saini, Mohammad Irfan Dar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of the Scientific Society |
Subjects: | |
Online Access: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2023;volume=50;issue=2;spage=235;epage=237;aulast=Batt |
Similar Items
-
Multisystem inflammatory syndrome in adults: Underdiagnosed??
by: T S Ravindra, et al.
Published: (2023-01-01) -
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome
by: İlker Devrim, et al.
Published: (2022-08-01) -
A retrospective study of children with multisystemi nflammatory syndrome and intravenous immunoglobulin treatment
by: Kolla Sravani, et al.
Published: (2022-01-01) -
“Multisystem Inflammatory Syndrome in Children” (MIS-C) after COVID-19 Infection in the Metropolitan Area of Nuremberg-Erlangen, Germany—Expectations and Results of a Two-Year Period
by: Steven Hébert, et al.
Published: (2023-08-01) -
Hematological Parameters and Inflammatory Markers in Children with Multisystem Inflammatory Syndrome
by: Gülsüm Alkan, et al.
Published: (2022-08-01)